Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Vascular System

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43881   clinical trials with a EudraCT protocol, of which   7295   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    458 result(s) found for: Vascular System. Displaying page 1 of 23.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2008-005006-39 Sponsor Protocol Number: selene 2008 Start Date*: 2009-02-24
    Sponsor Name:AZIENDA OSPEDALIERA PISANA
    Full Title: Study on the vascular effects of ACE-I + CA-antagonist (Enalapril + Lercanidipine) versus ACE-I + diuretic (Enalapril + hydrochlorothiazidE) combinations in hypertensive patients with metabolic syn...
    Medical condition: hypertensive patients of either sex aged 40-69 years
    Disease: Version SOC Term Classification Code Term Level
    9.1 10057166 HLGT
    9.1 10047065 SOC
    9.1 10047065 SOC
    9.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-013681-92 Sponsor Protocol Number: PREVENT-ICARUS V1 Start Date*: 2009-10-29
    Sponsor Name:AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
    Full Title: PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: IntraCoronary Adenosine administration to prevent peRiprocedUral myonecro...
    Medical condition: Elective coronary angioplasty
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-006304-38 Sponsor Protocol Number: 1381/08 Start Date*: 2008-12-23
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: Protocol for a study on male patients suffering from peripheral arterial disease with severe chronic limb ischemia during treatment with iloprost: assessment of oxidative stress and organic erectil...
    Medical condition: peripheral arterial disease and organic erectile dysfunction.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047065 Vascular disorders SOC
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-017640-13 Sponsor Protocol Number: Blocchi09 Start Date*: 2010-04-21
    Sponsor Name:ISTITUTI ORTOPEDICI RIZZOLI
    Full Title: Continuous peripheral block in the pain and ischemic ulcer treatment in arteriopathy patients
    Medical condition: Arteriophaty patients with ischemic pain and/or ulcers
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-017448-15 Sponsor Protocol Number: GAIN Start Date*: 2009-12-15
    Sponsor Name:ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED
    Full Title: A multicenter, open label, hystorical Group controlled study by evaluate the effectivness and sAfety in the use of INfliximab (Tumor necrosis factor - alfa antibody) in preventing or reducing cereb...
    Medical condition: patient with cerebral hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-001347-21 Sponsor Protocol Number: EPA 2007 Start Date*: 2007-03-05
    Sponsor Name:OSPEDALE POLICLINICO S. MATTEO
    Full Title: A randomised clinical trial on heparin versus saline solution (NaCl 0,9%) in the maintenance of peripherical venous catheters
    Medical condition: PVC flow maintenance
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-005056-16 Sponsor Protocol Number: ATORV/IMAPERIPROC Start Date*: 2007-10-19
    Sponsor Name:OSPEDALE S. RAFFAELE
    Full Title: Atorvastatin at high dosage before coronary stent surgery: effect on peri-procedure miocardic stroke .
    Medical condition: elective PCI in de novo coronaric lesions
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-001660-23 Sponsor Protocol Number: AOCP[1].IIb.Prot.DiSalvo.Mazzone.f Start Date*: 2007-11-12
    Sponsor Name:CENTRO STUDI FADOI
    Full Title: Optimized treatment of patients with severe peripheral arterial disease (Leriche-Fontaine stage IIb), when open or endovascular intervention is possible or not, in terms of measurement of pain free...
    Medical condition: Arteropatia obliterante cronica periferica
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-000966-10 Sponsor Protocol Number: 38/2004/U/sper Start Date*: 2004-03-23
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: na
    Medical condition: ESSENTIAL HYPERTENSION
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2016-002157-38 Sponsor Protocol Number: 57911 Start Date*: 2017-09-14
    Sponsor Name:Radboud University Medical Center
    Full Title: Treatment of congenital vascular malformations using Sirolimus: improving quality of Life
    Medical condition: congenital vascular malformation : Vascular malformations can involve lymphatic vessels, capillaries, veins and arteries or even combinations. These vascular malformations are present at birth an...
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000005125 10047091 Vascular malformations and acquired anomalies HLT
    20.0 100000158692 10047090 Vascular malformation peripheral LLT
    20.0 10017947 - Gastrointestinal disorders 10070181 Gastrointestinal vascular malformation PT
    20.0 10010331 - Congenital, familial and genetic disorders 10074979 Vascular malformation PT
    Population Age: Infants and toddlers, Children, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2011-005330-18 Sponsor Protocol Number: ARMYDA_CAROTID Start Date*: 2011-11-08
    Sponsor Name:UNIVERSITA' CAMPUS BIOMEDICO
    Full Title: Prospective randomized study to evaluate the efficacy of different protocols IN DRUG PREVENTION OF BRAIN DAMAGE AFTER Carotid angioplasty with stent implantation (CAROTID ARMYDA trial).
    Medical condition: Patients with carotid stenosis undergoing angioplasty with stent implantation
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10047065 Vascular disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-003627-29 Sponsor Protocol Number: PREVENTIHSSTUDY(FARM12L9JE) Start Date*: 2017-02-22
    Sponsor Name:OSPEDALE SANTA MARIA DELLA MISERICORDIA
    Full Title: PREvention of VENous Thromboembolism In Hemorrhagic Stroke patients
    Medical condition: hemorrhagic stroke
    Disease: Version SOC Term Classification Code Term Level
    20.0 10047065 - Vascular disorders 10047065 Vascular disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-000868-15 Sponsor Protocol Number: PENT_PTA Start Date*: 2012-03-06
    Sponsor Name:UNIVERSITA' CAMPUS BIOMEDICO
    Full Title: EFFECT OF TREATMENT WITH PENTOXIFYLLINE ABOUT THE RISK RATER OF POST-angioplasty restenosis IN PATIENTS WITH LOWER LIMB arterial disease
    Medical condition: PERIPHERAL ARTERIOPATHY
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10047065 Vascular disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-004583-22 Sponsor Protocol Number: 548.12 Start Date*: 2012-10-20
    Sponsor Name:OSPEDALE PEDIATRICO BAMBINO GESU' DI ROMA
    Full Title: Verification of the effectiveness of intravenous sildenafil compared to other pulmonary vasodilators used in the test vessel reactivity of pulmonary
    Medical condition: Subjects in children with congenital heart disease surgery or not, with echocardiographic signs of pulmonary hypertension followed at the Pediatric Cardiology Centre of the Mediterranean or reporte...
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10047065 Vascular disorders SOC
    Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-002314-21 Sponsor Protocol Number: MEN IFR/08/NEB-HYP/01 Start Date*: 2008-05-23
    Sponsor Name:A. MENARINI I.F.R.
    Full Title: VALUTAZIONE COMPARATIVA DEGLI EFFETTI SULLA FUNZIONE ENDOTELIALE DEL TRATTAMENTO CON NEBIVOLOLO E IDROCLOROTIAZIDE VS IRBESARTAN E IDROCLOROTIAZIDE IN PAZIENTI CON IPERTENSIONE ARTERIOSA NEO-DIAGNO...
    Medical condition: IPERTENSIONE ARTERIOSA
    Disease: Version SOC Term Classification Code Term Level
    9.1 10015488 Essential hypertension LLT
    9.1 10047065 Vascular disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-001635-21 Sponsor Protocol Number: VIA-2291-02 Start Date*: 2006-12-21
    Sponsor Name:VIA PHARMACEUTICALS, INC.
    Full Title: A Phase 2 Randomised, Double-blind, Placebo-controlled Study of the Effects of VIA-2291, a 5-lipoxygenase Inhibitor, on Atherosclerotic Plaque and Biomarkers of Vascular Inflammation in Patients wi...
    Medical condition: Carotid Stenosis.
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-010399-10 Sponsor Protocol Number: STAT Start Date*: 2009-04-16
    Sponsor Name:OSPEDALE G.PASQUINUCCI-FONDAZIONE G.MONASTERIO
    Full Title: STANDARD VERSUS TAILORED ANTI-PLATELET THERAPY IN ACS PATIENTS UNDERGOING PERCUTANEOUS CORONARY ANGIOPLASTY
    Medical condition: PATIENTS UNDERGOING CORONARY ANGIOPLASTY FOR ACUTE CORONARY SYNDROME TYPE STEMI / NSTEMI ESC
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047065 SOC
    9.1 10007541 SOC
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-004146-41 Sponsor Protocol Number: 49RC18_0197 Start Date*: 2019-01-30
    Sponsor Name:CHU Angers
    Full Title: First-BLINDOS - Evaluation d’une stratégie de dépistage systématique de la carence en vitamine D et du traitement en cas de déficit, sur l’amélioration de la distance maximale de marche chez les pa...
    Medical condition: Artériopathie oblitérante des membres inférieurs de stade 2
    Disease: Version SOC Term Classification Code Term Level
    20.0 10047065 - Vascular disorders 10003216 Arteriosclerosis, stenosis, vascular insufficiency and necrosis HLGT
    20.0 10047065 - Vascular disorders 10047065 Vascular disorders SOC
    20.0 10047065 - Vascular disorders 10062585 Peripheral arterial occlusive disease PT
    20.0 10047065 - Vascular disorders 10074575 Peripheral arterial occlusive disease Fontaine stage IIa LLT
    20.0 10047065 - Vascular disorders 10074576 Peripheral arterial occlusive disease Fontaine stage IIb LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-007516-15 Sponsor Protocol Number: HEP/NEB082000N/NEB4.01 Start Date*: 2009-02-02
    Sponsor Name:Laboratoires NEGMA
    Full Title: Comparaison des effets du nébivolol et de l'aténolol sur la fonction endothéliale vasomotrice des artères de conductance lors de l'hypertension artérielle essentielle
    Medical condition: Hypertension artérielle
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020775 Hypertension arterial LLT
    9.1 10047065 Vascular disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-005720-15 Sponsor Protocol Number: CLZC696A2224 Start Date*: 2013-09-11
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A randomized, double-blind, active-controlled, parallel group, 52-week study to evaluate the effect of LCZ696 compared to olmesartan on regional aortic stiffness in subjects with essential hyperten...
    Medical condition: Hypertensive patients.
    Disease: Version SOC Term Classification Code Term Level
    18.0 10047065 - Vascular disorders 10047065 Vascular disorders SOC
    18.0 10047065 - Vascular disorders 10015488 Essential hypertension PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed) DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon May 20 01:45:39 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA